The goal of this study was to develop and
test risperidone-loaded bioflexi films for the treatment of autism. Biopolymer
was extracted from Euryale ferox seeds (family Nymphaeaceae) for the production
of bioflexi films using a cost-effective approach. Infrared spectroscopy (IR),
differential scanning colorimetry (DSC), scanning electron microscopy (SEM),
nuclear magnetic resonance (NMR), and cell line toxicity studies were used to
evaluate the biopolymer recovered from the concentrate.
Methods: In a methanol and water solvent solution, bioflexi films were made
using this biopolymer, dextrose as a flexicizer, and sween 80 as a permeation
enhancer.
The weight uniformity, medication content, folding endurance, and thickness of the formulations were all measured. To quantify the amount of risperidone contained in the patches, in vitro dissolution of the experimental formulations was performed, and scanning electron microscopy of the produced bioflexi films was taken to examine the drug distribution pattern. The Fourier transform infrared spectroscopy technique was used to study drug-excipient interactions. In vitro dissolution investigations revealed that drug distribution in the bioflexi film was homogeneous, and that the maximal drug release in 24 hours with formulation EF3 was 99.81 percent. A modified Franz's diffusion cell was used to conduct an in vitro skin permeation research, which revealed that the maximum penetration with the formulation EF3 was 768.50 g/cm2 after 24 hours.
Conclusion: Optimized formulations were
determined to be suitable for formulation in terms of physicochemical
properties, and no significant interaction between the medicine and the
biopolymer utilised was observed.
Author (S) Details
Bhavana Singh
School of
Pharmaceutical Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun,
Uttarakhand, India.
N. V. S. Madhav
Vital Therapeutics and Formulation Pvt. Ltd. Secunderband, Telangana,
India.
View
Book :- https://stm.bookpi.org/TIPR-V11/article/view/3128
No comments:
Post a Comment